Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
Secure Logon Learn More 
* For Financial Representatives *
and Operations Personnel Only
User Id:
Help, I Forgot My Password!
Benefits of Registration

Subscribe to First Trust commentary and analysis.

Bob Carey
Chief Market Strategist
Brian Wesbury
Chief Economist
Investment Insights
FINRA's BrokerCheck
Check the background of
First Trust using FINRA's BrokerCheck.
Factoid of the Day Tuesday, October 25, 2016
The Centers for Disease Control reported that nearly half of all Americans took at least one prescription drug in the past month, and one in five uses three or more, according to The Fiscal Times. Prescription drug prices are headed for double-digit increases in 2017. The overall cost of all drugs prescribed for employees under age 65 is expected to rise by 11.6% in 2017, on top of an 11.3% hike in 2016. Specialty drug prices are projected to increase by 18.7% in 2017. Prices rose by 18.9% in 2016. Specialty drugs account for less than 1% of prescriptions. In 2016, 4.4 billion drug prescriptions were given to Americans, according to IMS Health.
Brian Wesbury - Economic Video Commentary
Rate Hikes Won't Matter

Bob Carey - Video Market Update
Tis the Season for Earnings

New ETFs - Exchange Listing Date: September 28, 2016

First Trust Mobile
Learn about our Mobile SiteGet the latest First Trust product and research information on your smartphone or tablet device!
Learn more...

Institutional Investors
Unit Investment Trusts
Variable Annuities
Closed-End Funds
Exchange-Traded Funds
Open End Mutual Funds

Structured Products
Seperate Managed Accounts


First Trust Indexes

First Trust Investment Banking
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2016 All rights reserved.